This work conducted a species-wide genome-wide association study of invasion and compared the prevalence of significant unitigs in GPSC1 and GPSC21 to identify invasion-associated variants differentiating them, and highlighted candidate proteins that may help explain invasiveness and could be explored as vaccine antige...
M. Pesonen, O. Lorenz, M. du Plessis et al.· bioRxiv· 0 citations
A single dose of MenACYW-TT induced non-inferior immune responses and a comparable safety profile versus MenACYW-DT in children and adolescents aged 2-17 years was demonstrated.
Ashish Bavdekar, D. Chansinghakul, Ravi Mandyam Dhati et al.· Vaccine· 0 citations
A reduced PCV13 1+1 schedule, primed at either 6 weeks or 14 weeks, maintained non-inferior serotype-specific GMCs relative to the PCV13 2+1 schedule up until age 5 years, supporting schedule transition in countries with well established PCV programmes.
Daniel Kapelus, C. Olwagen, A. Izu et al.· The Lancet Child & Adolescen...· 0 citations
Clesrovimab is a new medicine that helps protect babies against severe RSV disease and is currently very expensive, which means that it is not yet likely to be widely available through public healthcare systems in many low- and middle-income countries.
M. Wiedenmann, Z. Dangor, S. Madhi· Expert Review of Respiratory...· 0 citations
Findings identify resveratrol as a promising anti-virulence candidate and highlight the utility of integrative computational and experimental strategies for the identification of compounds targeting quorum sensing and biofilm formation inhibition in multidrug-resistant pathogens.
Mashego Jackson Mamosebo, Suheena Ayrga, S. Madhi et al.· Archives of Microbiology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.